Kukje Pharma Co Ltd (002720) — Capital Reinvestment Ratio
Kukje Pharma Co Ltd (002720) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.99 Billion) in capital expenditures (₩474.52 Million). Check 002720 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kukje Pharma Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Kukje Pharma Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Kukje Pharma Co Ltd (002720) cash flow conversion.
Annual Capital Reinvestment Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Kukje Pharma Co Ltd from 2011 to 2024. See Kukje Pharma Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩2.99 Billion | ▲ +159.8% |
| 2023 | 0.29x | ₩3.58 Billion | ₩1.05 Billion | ▲ +51.1% |
| 2022 | 0.19x | ₩6.50 Billion | ₩1.26 Billion | ▼ -1.8% |
| 2021 | 0.20x | ₩9.60 Billion | ₩1.89 Billion | ▼ -91.3% |
| 2020 | 2.27x | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.63x | ₩3.60 Billion | ₩5.89 Billion | ▲ +615.1% |
| 2018 | 0.23x | ₩13.25 Billion | ₩3.03 Billion | ▼ -93.1% |
| 2017 | 3.32x | ₩786.10 Million | ₩2.61 Billion | ▲ +1889.6% |
| 2016 | 0.17x | ₩16.10 Billion | ₩2.69 Billion | ▼ -83.4% |
| 2012 | 1.00x | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩17.39 Billion | ₩1.00 Billion | — |